PVRL2 upregulation by tumor-associated macrophages confers a regulatory phenotype and is associated with poor prognosis in high-grade serous ovarian cancer

被引:0
|
作者
Murakami, Kosuke
Ando, Hirofumi
Doucet, Michele
Ding, Dacheng
Huang, William
Ganguly, Sudipto
机构
关键词
D O I
10.1158/1538-7445.AM2024-165
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
165
引用
收藏
页数:2
相关论文
共 50 条
  • [31] High Infiltration of Tumor-Associated Macrophages is Associated With a Poor Response to Chemotherapy and Poor Prognosis of Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Cancer
    Sugimura, Keijiro
    Miyata, Hiroshi
    Tanaka, Koji
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Yamasaki, Makoto
    Nakajima, Kiyokazu
    Takiguchi, Shuji
    Mori, Masaki
    Doki, Yuichiro
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (06) : 752 - 759
  • [32] YKL40/Integrin β4 Axis Induced by the Interaction between Cancer Cells and Tumor-Associated Macrophages Is Involved in the Progression of High-Grade Serous Ovarian Carcinoma
    Yamanaka, Keitaro
    Koma, Yu-ichiro
    Urakami, Satoshi
    Takahashi, Ryosuke
    Nagamata, Satoshi
    Omori, Masaki
    Torigoe, Rikuya
    Yokoo, Hiroki
    Nakanishi, Takashi
    Ishihara, Nobuaki
    Tsukamoto, Shuichi
    Kodama, Takayuki
    Nishio, Mari
    Shigeoka, Manabu
    Yokozaki, Hiroshi
    Terai, Yoshito
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (19)
  • [33] Targeting mesothelin-CD24 axis repolarizes tumor-associated macrophages to potentiate PD-1 blockade therapy in high-grade serous ovarian cancer
    Zhong, Yujing
    Wang, Yiying
    Wang, Chenyang
    Cao, Kankan
    Wang, Xueling
    Xu, Xuyao
    Yang, Moran
    Zhang, Guodong
    Liu, Haiou
    Lu, Jiaqi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (02)
  • [34] Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer
    Skoeld, Camilla
    Corvigno, Sara
    Dahlstrand, Hanna
    Enblad, Gunilla
    Mezheyeuski, Artur
    Sundstroem-Poromaa, Inger
    Stalberg, Karin
    Tolf, Anna
    Glimelius, Ingrid
    Koliadi, Anthoula
    CANCER CAUSES & CONTROL, 2024, 35 (08) : 1101 - 1109
  • [35] Immune cell landscapes are associated with high-grade serous ovarian cancer survival
    Zhang, Guoan
    Zhang, Yan
    Zhang, Jingjing
    Yang, Xiaohui
    Sun, Wenjie
    Liu, Ying
    Liu, Yingfu
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [36] MOLECULAR AND FUNCTIONAL HETEROGENEITY OF CANCER ASSOCIATED FIBROBLASTS IN HIGH-GRADE SEROUS OVARIAN CANCER
    Hussain, Ali
    Voisin, Veronique
    Poon, Stephanie
    Meens, Jalna
    Dmytryshyn, Julia
    Paterson, Josh
    Bernardini, Marcus
    Bader, Gary
    Neel, Benjamin G.
    Ailles, Laurie E.
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 134 - 134
  • [37] The Scavenger Receptor MARCO Expressed by Tumor-Associated Macrophages Are Highly Associated With Poor Pancreatic Cancer Prognosis
    Shi, Bian
    Chu, Junfeng
    Huang, Tao
    Wang, Xiaoqian
    Li, Qiujian
    Gao, Qilong
    Xia, Qingxin
    Luo, Suxia
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [38] The number of cycles of neoadjuvant chemotherapy is associated with prognosis of stage IIIc–IV high-grade serous ovarian cancer
    Xia Xu
    Fei Deng
    Mengmeng Lv
    Xiaoxiang Chen
    Archives of Gynecology and Obstetrics, 2017, 295 : 451 - 458
  • [39] Identification of Malignant Cell Populations Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer Using Single-Cell RNA Sequencing
    Sumitani, Naoki
    Ishida, Kyoso
    Sawada, Kenjiro
    Kimura, Tadashi
    Kaneda, Yasufumi
    Nimura, Keisuke
    CANCERS, 2022, 14 (15)
  • [40] Tumor and local lymphoid tissue interaction determines prognosis in high-grade serous ovarian cancer
    Lu, Haonan
    Lou, Hantao
    Wengert, Georg
    Paudel, Reema
    Patel, Naina
    Desai, Saral
    Crum, Bill
    Linton-Reid, Kristofer
    Chen, Mitchell
    Li, Dongyang
    Ip, Jacey
    Mauri, Francesco
    Pinato, David J.
    Rockall, Andrea
    Copley, Susan J.
    Ghaem-Maghami, Sadaf
    Aboagye, Eric O.
    CELL REPORTS MEDICINE, 2023, 4 (07)